US9314271084 - Common Stock
WALGREENS BOOTS ALLIANCE INC
NASDAQ:WBA (4/26/2024, 7:23:53 PM)
After market: 17.75 +0.05 (+0.28%)17.7
+0.1 (+0.57%)
Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. The company is headquartered in Deerfield, Illinois and currently employs 206,000 full-time employees. The company went IPO on 2014-12-31. Its segments include U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment includes the Walgreens business, which includes the operations of retail drug stores, health and wellness services, and specialty and home delivery pharmacy services, and its equity method investment in Cencora, Inc. The International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution business in Germany. The pharmacy-led health and beauty retail businesses include Boots branded stores in the United Kingdom, the Republic of Ireland and Thailand, the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omni-channel experience across the care journey.
WALGREENS BOOTS ALLIANCE INC
108 Wilmot Rd
Deerfield ILLINOIS 60015
P: 18473152500
CEO: Rosalind Brewer
Employees: 206000
CNBC's Jim Cramer on Friday walked investors through next week on Wall Street.
Among the company's investments to "transform" its specialty pharmacy services is the opening of a new facility dedicated to cell and gene therapy services.
Walgreens Boots Alliance Inc. is opening a new center dedicated to bringing emerging cell and gene therapies to patients with complex, chronic conditions like cancer, cystic fibrosis and Crohn’s disease.
Here you can normally see the latest stock twits on WBA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: